Moonlake Immunotherapeutics · NASDAQ:MLTX

Santos da Silva Jorge sold 102,225 Moonlake Immunotherapeutics shares (Form 4)

Traded Jul 9 to Jul 10, 2026 · Filed Jul 13, 2026

From Jul 9 to Jul 10, 2026, Santos da Silva Jorge (Director, Chief Executive Officer) sold 102,225 Moonlake Immunotherapeutics shares at an average US$20.02 for US$2.05M under a trading plan, leaving 2,774,893 shares. Filed Jul 13, 2026 (Form 4).

Sold
102,225 shares
Price
US$20.02 average (US$20.01 to US$20.02)
Value
US$2.05M
Holding after
2,774,893 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 9, 2026Class A ordinary shares, par value $0.0001 per shareSale33,936US$20.012,843,182Direct
Jul 10, 2026Class A ordinary shares, par value $0.0001 per shareSale68,289US$20.022,774,893Direct

Source

View original at SEC

Related